Read more...

Read more...


Read more...


Serena commentary: Suggested minimal evidence for CAMP coverage

Dr Thomas Serena discusses the consequences in real-time of not providing guidance on the minimal amount of evidence required to recommend a CAMP (cellular, acellular matrix-based product) for patients. He argues that more clinical evidence needs to be published to support their efficacy.

Navigating obstacles impacting the sustainability of Medicare-funded wound care pricing

As the US population continues to age, costs for hard-to-heal wounds are expected to rise and negatively contribute to the long-term financial stability of Medicare, which is currently labelled a ‘high-risk’ program by the US Government Accountability Office. 

Treatment patterns and outcomes of Medicare enrolees who developed venous leg ulcers

Comorbidities, treatment patterns and outcomes of Medicare enrolees who developed venous leg ulcers (VLUs) were retrospectively evaluated. Patients diagnosed with chronic venous insufficiency (CVI) and a VLU were propensity matched into four groups based on their treatment regimen.